K.E.W. Melvin

524 total citations
11 papers, 365 citations indexed

About

K.E.W. Melvin is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Nephrology. According to data from OpenAlex, K.E.W. Melvin has authored 11 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Epidemiology and 2 papers in Nephrology. Recurrent topics in K.E.W. Melvin's work include Thyroid Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Dermatological and Skeletal Disorders (1 paper). K.E.W. Melvin is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Dermatological and Skeletal Disorders (1 paper). K.E.W. Melvin collaborates with scholars based in United Kingdom, United States and France. K.E.W. Melvin's co-authors include A H Tashjian, G. F. Joplin, Giraud V. Foster, I. MacIntyre, James R. Givens, Carl E. Cassidy, J. D. K. North, Michael A. Beaven, Stephen B. Baylin and Harry R. Keiser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Metabolism.

In The Last Decade

K.E.W. Melvin

11 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.E.W. Melvin United Kingdom	8	161	88	72	66	62	11	365
Betty S. Roof United States	12	100 0.6×	48 0.5×	88 1.2×	60 0.9×	95 1.5×	20	390
Penn G. Skillern United States	13	236 1.5×	50 0.6×	58 0.8×	53 0.8×	102 1.6×	26	461
John F. Hennessy United States	7	203 1.3×	90 1.0×	66 0.9×	95 1.4×	49 0.8×	11	362
John Wiswell United States	9	148 0.9×	31 0.4×	51 0.7×	54 0.8×	56 0.9×	18	343
Kaplan El United States	10	174 1.1×	54 0.6×	79 1.1×	43 0.7×	124 2.0×	27	345
Carl E. Cassidy United States	13	333 2.1×	47 0.5×	42 0.6×	66 1.0×	55 0.9×	21	450
Harry T. McPherson United States	11	186 1.2×	41 0.5×	50 0.7×	134 2.0×	84 1.4×	14	452
L. M. Sandler United Kingdom	11	205 1.3×	102 1.2×	113 1.6×	65 1.0×	72 1.2×	17	524
E. T. Lonergan United States	9	76 0.5×	46 0.5×	21 0.3×	55 0.8×	37 0.6×	13	356
C Augeri Italy	9	137 0.9×	97 1.1×	72 1.0×	75 1.1×	98 1.6×	14	365

Countries citing papers authored by K.E.W. Melvin

Since Specialization

Citations

This map shows the geographic impact of K.E.W. Melvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.E.W. Melvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.E.W. Melvin more than expected).

Fields of papers citing papers by K.E.W. Melvin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.E.W. Melvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.E.W. Melvin. The network helps show where K.E.W. Melvin may publish in the future.

Co-authorship network of co-authors of K.E.W. Melvin

This figure shows the co-authorship network connecting the top 25 collaborators of K.E.W. Melvin. A scholar is included among the top collaborators of K.E.W. Melvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.E.W. Melvin. K.E.W. Melvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Baylin, Stephen B., Michael A. Beaven, Harry R. Keiser, A H Tashjian, & K.E.W. Melvin. (1972). SERUM HISTAMINASE AND CALCITONIN LEVELS IN MEDULLARY CARCINOMA OF THE THYROID. The Lancet. 299(7748). 455–458. 45 indexed citations

2.

Melvin, K.E.W., A H Tashjian, Carl E. Cassidy, & James R. Givens. (1970). Cushing's syndrome caused by ACTH- and calcitonin-secreting medullary carcinoma of the thyroid. Metabolism. 19(10). 831–838. 53 indexed citations

3.

Melvin, K.E.W. & A H Tashjian. (1968). The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid.. Proceedings of the National Academy of Sciences. 59(4). 1216–1222. 127 indexed citations

4.

Joplin, G. F., K.E.W. Melvin, Gershon W. Hepner, G. Neale, & P Bordier. (1968). Calcium metabolism and bone histology in adult celiac disease. Calcified Tissue International. 2(S1). 62–62. 1 indexed citations

5.

Melvin, K.E.W., et al.. (1967). Acute metabolic response to human growth hormone in different types of dwarfism.. BMJ. 3(5559). 196–199. 9 indexed citations

6.

Foster, Giraud V., et al.. (1966). EFFECT OF THYROCALCITONIN IN MAN. The Lancet. 287(7429). 107–109. 69 indexed citations

7.

Melvin, K.E.W., et al.. (1966). Articular Chondrocalcinosis, Hyperparathyroidism and Pseudogout: Hypomagnesæmic Crisis. Proceedings of the Royal Society of Medicine. 59(7). 595–596. 7 indexed citations

8.

Melvin, K.E.W., et al.. (1965). Œsophageal Polyp with Hypertrophic Osteoarthropathy. Proceedings of the Royal Society of Medicine. 58(8). 576–577. 8 indexed citations

9.

Melvin, K.E.W., et al.. (1963). EFFECT OF BLOOD-TRANSFUSION ON RENAL EXCRETORY FUNCTION IN CHRONIC RENAL FAILURE. The Lancet. 282(7307). 537–539. 4 indexed citations

10.

Melvin, K.E.W., et al.. (1963). Ethacrynic Acid: A New Oral Diuretic. BMJ. 1(5344). 1521–1524. 31 indexed citations

11.

Melvin, K.E.W. & R. Nicole Howie. (1961). Fatal Case of Stevens-Johnson Syndrome after Sulphamethoxypyridazine Treatment. BMJ. 2(5256). 869–870. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact